Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted therapies for patients diagnosed with cancer. Rather than analyzing one gene at a ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

Do microorganisms truly reside in tumors, or do the samples become contaminated before sequencing occurs? A new computational ...

The landscape of metastatic prostate cancer (mPCa) treatment has evolved significantly with the advent of targeted therapies, particularly poly (ADP-ribose) polymerase inhibitors (PARPis). 1 However, ...

They include the “Jolie” gene, named after actress Angelina Jolie, who had preventative surgery after finding out she had a ...

In recognition of February Cancer Prevention Month, jscreen®, the national nonprofit focused on preventing genetic diseases through accessible testing and education, is partnering with Manischewitz® ...

Nonprofit senior living operator FellowshipLife recently launched a new, voluntary genetic testing program for residents and their families aimed at ...